| Canada leads the world in bio firms per capita, with Ontario home to more than half the country's brand-name pharmaceutical and medical devices industries, and almost half the medical biotechnology industry. |
|
| Ontario's biotech industry: |
|
| • | Canada's largest - and North America's 3rd largest - regional concentration of biotechnology firms |
| • | Over 130 biotech companies and 60 research centres. |
| • | 2,500 highly educated scientists, engineers and technicians. |
| • | Generates 53% of Canada's Biotechnology Revenue. |
| • | Revenues of US $1.6 billion (CDN $2.2 billion) in 2003. |
|
 |
|
| Ontario's pharmaceutical industry: |
|
| • | 16,250 employees |
| • | Recorded sales of approximately US $5.5 billion (CDN $6.7 billion) in 2005 |
| • | Key operations by global pharmaceutical giants such as GlaxoSmithKline, AstraZeneca and Eli Lilly. |
| • | Pharmaceutical R&D expenditures in Ontario doubled in the last decade to nearly $480 million in 2002 |
| • | Home to over 50% of Canada's pharmaceutical companies |
|
| Data from Ontario clinical trials is recognized by American and European medical authorities |
|
| Ontario's medical devices industry: |
|
| • | 22,000 employees |
| • | 600 companies |
| • | Recorded revenues of US $3.8 billion (CDN $5 billion) in 2004 |
| • | Home to more than 60% of Canada’s Medical and Assistive Technologies (MAT) companies |
| • | Includes global companies such as GE Medical Systems, Siemens and Johnson & Johnson Medical Products |
|
| All figures in US dollars. |
